Skip to content

In the BioHarmony Drug Report Database

Carbidopa

Lodosyn, Corbilta, Levodopa/Carbidopa/Entacapone Orion, Levodopa/Carbidopa/Entacapone Sandoz, Stalevo (carbidopa) is a small molecule pharmaceutical. Carbidopa was first approved as Lodosyn on 1982-01-01. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against aromatic-L-amino-acid decarboxylase.
Trade Name Corbilta, Levodopa/Carbidopa/Entacapone Orion, Levodopa/Carbidopa/Entacapone Sandoz, Stalevo
Common Name Carbidopa
Indication parkinson disease
Drug Class Dopamine receptor agonists
Carbidopa
Get full access now